MIR-590-5p-meidated LOX-1 upregulation promotes Angiotensin II-induced endothelial cell apoptosis

Biochemical and Biophysical Research Communications

Volumn 471, Issue 4, 2016, Pages 402-408

  Luo, Ping ^a,b   Zhang, Wei Fang ^c   Qian, Zhao Xin ^b   Xiao, Ling Fang ^b   Wang, Hui ^a   Zhu, Tian Tian ^a   Li, Feng ^a   Hu, Chang Ping ^a   Zhang, Zheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

Author keywords

Angiotensin II; Apoptosis; HUVECs; LOX 1; MIR 590 5p

Indexed keywords

ANGIOTENSIN II; CASPASE 3; MICRORNA; MICRORNA 590 5P; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN590 MICRORNA, HUMAN; OLR1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; APOPTOSIS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; REACTIVE OXYGEN SPECIES; SCAVENGER RECEPTORS, CLASS E; UP-REGULATION;

EID: 84975783942     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.02.074     Document Type: Article

References (30)

1. E. Rojas, D. Rodríguez-Molina, P. Bolli, Z.H. Israili, J. Faría, E. Fidilio, and et al. The role of adiponectin in endothelial dysfunction and hypertension Curr. Hypertens. Rep. 16 2014 463
2. J. Zhao, L. Chen, B. Shu, J. Tang, L. Zhang, J. Xie, and et al. Angiopoietin-1 protects the endothelial cells against advanced glycation end product injury by strengthening cell junctions and inhibiting cell apoptosis J. Cell. Physiol. 230 2015 1895 1905
3. Y. Xue, Z. Wei, H. Ding, Q. Wang, Z. Zhou, S. Zheng, and et al. MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis Atherosclerosis 241 2015 671 681
4. H.-Y. Yang, Y.-F. Bian, H.-P. Zhang, F. Gao, C.-S. Xiao, B. Liang, and et al. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells Clin. Exp. Pharmacol. Physiol. 39 2012 1004 1010
5. Q. Wang, M. Zhang, Y. Ding, Q. Wang, W. Zhang, P. Song, and et al. Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo Circ. Res. 114 2014 480 492
6. H. Wen, J.K. Gwathmey, and L.-H. Xie Oxidative stress-mediated effects of angiotensin II in the cardiovascular system World J. Hypertens. 2 2012 34 44
7. D.P. Bartel MicroRNAs: Target recognition and regulatory functions Cell. 136 2009 215 233
8. A.J. Favreau, and P. Sathyanarayana miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia Leuk. Res. 36 2012 334 341
9. X. Shan, Y. Miao, R. Fan, H. Qian, P. Chen, H. Liu, and et al. MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway Int. J. Mol. Sci. 14 2013 8556 8569
10. T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, and et al. An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77
11. D. Hong, Y.-P. Bai, H.-C. Gao, X. Wang, L.-F. Li, G.-G. Zhang, and et al. Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway Atherosclerosis 235 2014 310 317
12. H. Morawietz, U. Rueckschloss, B. Niemann, N. Duerrschmidt, J. Galle, K. Hakim, and et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein Circulation 100 1999 899 902
13. C. Hu, A. Dandapat, J. Chen, Y. Liu, P.L. Hermonat, R.M. Carey, and et al. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression Atherosclerosis 199 2008 288 294
14. C. Hu, B.-Y. Kang, J. Megyesi, G.P. Kaushal, R.L. Safirstein, and J.L. Mehta Deletion of LOX-1 attenuates renal injury following angiotensin II infusion Kidney Int. 76 2009 521 527
15. P. Luo, M. Yan, E.D. Frohlich, J.L. Mehta, and C. Hu Novel concepts in the genesis of hypertension: Role of LOX-1 Cardiovasc. Drugs Ther. Spons. Int. Soc. Cardiovasc. Pharmacother. 25 2011 441 449
16. W.-F. Zhang, Y.-Y. Xu, K.-P. Xu, W.-H. Wu, G.-S. Tan, Y.-J. Li, and et al. Inhibitory effect of selaginellin on high glucose-induced apoptosis in differentiated PC12 cells: Role of NADPH oxidase and LOX-1 Eur. J. Pharmacol. 694 2012 60 68
17. J. Chen, Y. Liu, H. Liu, P.L. Hermonat, and J.L. Mehta Molecular dissection of angiotensin II-activated human LOX-1 promoter Arterioscler. Thromb. Vasc. Biol. 26 2006 1163 1168
18. L. Zhang, M. Zhou, G. Qin, N.L. Weintraub, and Y. Tang MiR-92a regulates viability and angiogenesis of endothelial cells under oxidative stress Biochem. Biophys. Res. Commun. 446 2014 952 958
19. H. Shan, Y. Zhang, Y. Lu, Y. Zhang, Z. Pan, B. Cai, and et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines Cardiovasc. Res. 83 2009 465 472
20. B. Qin, B. Xiao, T. Jiang, and H. Yang [Effects of miR-590-5p on ox-LDL-induced endothelial cells apoptosis and LOX-1 expression] Zhong Nan Da Xue Bao Yi Xue Ban. 37 2012 675 681
21. M.-H. Bao, J.-M. Li, Q.-L. Zhou, G.-Y. Li, J. Zeng, J. Zhao, and et al. Effects of miR-590 on oxLDL-induced endothelial cell apoptosis: Roles of p53 and NF-κB Mol. Med. Rep. 13 2016 867 873
22. T. Sawamura, I. Wakabayashi, and T. Okamura LOX-1 in atherosclerotic disease Clin. Chim. Acta 440 2015 157 163
23. J. Guo, H. Chen, J. Ho, J. Mancini, T. Sontag, S.A. Laporte, and et al. TGFbeta-induced GRK2 expression attenuates AngII-regulated vascular smooth muscle cell proliferation and migration Cell. Signal 21 2009 899 905
24. X. Xiao, C. Zhang, X. Ma, H. Miao, J. Wang, L. Liu, and et al. Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways Exp. Cell Res. 336 2015 58 65
25. X. Wang, M. Khaidakov, Z. Guo, Z. Ding, Q. He, and J.L. Mehta LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II Cardiovasc. Drugs Ther. Spons. Int. Soc. Cardiovasc. Pharmacother. 28 2014 441 446
26. M.-S. Zhou, I. Hernandez Schulman, P.J. Pagano, E.A. Jaimes, and L. Raij Reduced NAD(P)H oxidase in low renin hypertension: Link among angiotensin II, atherogenesis, and blood pressure Hypertension 47 2006 81 86
27. A. Akhmedov, I. Rozenberg, F. Paneni, G.G. Camici, Y. Shi, C. Doerries, and et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo Eur. Heart J. 35 2014 2839 2848
28. C. Hu, A. Dandapat, L. Sun, M.R. Marwali, N. Inoue, F. Sugawara, and et al. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion Hypertension 52 2008 556 562
29. M. Fukui, M. Tanaka, T. Senmaru, M. Nakanishi, J. Mukai, M. Ohki, and et al. LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes Metabolism 62 2013 935 938
30. T.E. Brinkley, N. Kume, H. Mitsuoka, D.A. Phares, and J.M. Hagberg Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women Obes. Silver Spring Md 16 2008 1454 1456